|
Below is a listing of webinars hosted by HealthLeaders-InterStudy.
Enrollment in commercial managed care organizations (MCO) is showing signs of making a rebound in the coming year, according to the latest data from HealthLeaders-InterStudy. In this webinar we’ll examine why some markets are doing better than others and where the pharmaceutical industry can expect the most opportunity in the next year. This presentation will analyze the impact of MCO enrollment shifts on the pharmaceutical industry in both the commercial and government sectors.
After attending this webinar, you will have a better understanding of:
- What enrollment trends are in the commercial, Medicare and Medicaid markets.
- Where HMOs and consumer-driven health plans are bucking the trend and increasing enrollment, and what that means for pharma benefits.
- How employers are turning to narrow-network products and self-insured plans to keep costs down.
- Why Medicare Advantage MCOs have experienced some losses, and what that means for 2011.
This webinar will include a case study of effective field strategy coordination using HealthLeaders-InterStudy’s Integrated Payer Platform that combines data about health plans, PBMs and employer health benefits into one streamlined view.
Click here to access a recorded playback of this presentation.
Medicaid enrollment is up substantially and with budget deficits and declining tax revenue, states are desperate to control costs. With health care reform expected to add 16 million more enrollees to CHIP and Medicaid roles, more changes and innovations are expected from states.
Because each state Medicaid program’s eligibility, benefits and management is different, understanding state-level data and analysis is imperative to identify opportunities and risks in this rapidly changing environment.
This webinar will address Medicaid trends HealthLeaders-InterStudy analysts are following across the country. By attending this presentation, you will learn more about:
- The recession’s impact on Medicaid enrollment trends at the national, state and local level.
- How health reform legislation will affect drug benefits and other facets of the program.
- Targeting managed care plans as they move into the aged, blind and disabled segments.
- Identifying partnering opportunities in patient-centered medical homes rolling out across the country.
Click here to access a recorded playback of this presentation.
Despite share declines in commercial enrollment, the health insurance industry has been holding steady and even improving profits in a difficult economy. This analyst call, open to Health Plan Data & Analysis subscribers, will answer the following questions:
-
What does the commercial market look like for major insurers in 2010?
-
What are health plans looking at in the way of wellness programs and narrow networks as part of value-based insurance design?
-
What kind of growth can be expected in the Medicaid and Medicare markets, and which insurers look especially strong in these areas?
Contact us to learn how you can attend this webinar.
Based on the Formulary Forum report of the immune biologics market, our sister company Decision Resources is offering an in-depth webinar entitled How Will My Brand Be Affected? An Examination of the Reimbursement and Prescribing of Immune Biologics and the Emergence of Novel Cost Control Measures. Because this webinar will feature major findings, it is ONLY available to purchasers of the Formulary Forum report entitled Formulary Advantages in Immune Biologics: Tightening Payer Control Offers Opportunities for Differentiation.
Click here to learn how you can purchase the report and access a recorded playback of the event.
Based on our Formulary Forum data and analysis of the Type 2 diabetes market, HealthLeaders-InterStudy is offering an in-depth webinar entitled Formulary Status and the Type 2 Diabetes Market: Emerging Drugs and Their Uphill Battle. Because this webinar will feature major findings, it is ONLY available to purchasers of the Formulary Forum report entitled Formulary Advantages in Type 2 Diabetes: Impact of Current and Future DPP-IV Inhibitors and GLP-1 Analogues on Advantaged Reimbursement Status for Key Brands.
Click here to learn how you can purchase the report and access a recorded playback of the event.
Market Overview Analyst Dave Raiford highlights select findings from new reports in our Market Overview series, including how leading national trends are playing out at the local level in four of these markets:
- Colorado Springs, CO
- Columbia, SC
- Spokane, WA
- Wilmington, DE
Click here to access a recorded playback of this webinar.
Director of Market Analysis Jane Dubose and Vice President of Market Analysis Sheri Sellmeyer will highlight the product strategy of several large Blue Cross and Blue Shield plans, discuss their pharmacy benefits and talk about their financial trends.
Click here to access a recorded playback of this webinar.
|
